Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Leukemia, Myeloid, Acute
×
AP 1903 reagent
×
Clear all
Filters
3
NCT03699475
2023-09-29
THRIVE
Bellicum Pharmaceuticals
Phase 2/3
Terminated
1 enrolled
9 charts